Table 3.

CMH results for lead SNPs when genotype and pain are grouped by antidepressant use.

Chr	SNP	A1	MAF	A2	CHISQ	P	OR	SE	L95	U95
2	rs141909432	A	0.016	G	15.16	9.89x10−5	3.221	0.327	1.698	6.113
2	rs2968817	A	0.291	G	16.32	5.36x10−5	0.691	0.092	0.578	0.828
3	rs113388258	C	0.059	T	18.73	1.51x10−5	2.077	0.17	1.489	2.898
3	rs4624600	C	0.347	T	18.13	2.06x10−5	1.435	0.085	1.215	1.695
5	rs59442633	C	0.082	T	18.43	1.76x10−5	1.84	0.144	1.388	2.439
5	rs458909	A	0.017	C	17.48	2.90x10−5	3.581	0.323	1.9	6.748
8	rs11300774	T	0.246	TA	21.09	4.38x10−6	0.636	0.099	0.524	0.771
11	rs2123323	T	0.461	C	11.96	5.44x10−4	1.326	0.082	1.13	1.555
11	rs36106152	G	0.329	GA	16.44	5.03x10−5	0.699	0.089	0.588	0.831
12	rs71450224	A	0.262	AAAAG	16.62	4.56x10−5	0.677	0.096	0.561	0.817
17	rs12449867	C	0.336	T	16.68	4.43x10−5	1.415	0.085	1.197	1.672
17	rs9898347	A	0.355	G	12.4	4.30x10−4	0.737	0.087	0.622	0.874
17	rs34176221	AT	0.445	A	11.19	8.23x10−4	1.315	0.082	1.12	1.543
18	rs1619323	C	0.217	T	17.35	3.10x10−5	0.653	0.103	0.534	0.799
22	rs8137390	G	0.202	A	15.99	6.37x10−5	1.485	0.099	1.223	1.804